Outline
The present invention relates to a combination of two natural and a semi-synthetic active ingredient, and to a pharmaceutical composition thereof. Said combination is useful for the treatment and prevention of inflammatory phenomena, malignancies, in particular cancerous cell migration, furthermore of complications following COVID-19 viral infections.

The physiological effect of the combination was demonstrated by showing the effect on the proliferation of a cell line formed from Lewis lung adenoma carcinoma, the effect on the metastasis formation of transplanted tumour cells, and the effect in a preclinical muscle-lung model.

The product is recommended for application in the form of a small intestinal capsule or in the form of a suppository.